Age, years, mean±SD |
63.3±9 |
65.7±15 |
0.6 |
Gender, male, n (%) |
11 (73.3) |
31 (72.1) |
0.9 |
Duration of hospitalization (days), median (IQR) |
19 (11) |
15 (14) |
0.02 |
Admission to ICU interval (days), median (IQR) |
14.5 (22) |
6 (7) |
<0.001 |
Comorbidities, n (%) |
|
|
|
Diabetes mellitus |
6 (40) |
8/41 (19.5) |
0.2 |
Hypertension |
7 (46.7) |
19/40 (47.5) |
1 |
Coronary heart disease |
3 (20) |
6/40 (15) |
0.7 |
Heart failure |
1 (6.7) |
4/40 (10) |
0.7 |
Chronic renal failure |
3 (20) |
9 (21) |
1 |
Chronic obstructive pulmonary disease |
3 (20) |
9/41 (22) |
0.9 |
Malignancy |
1 (6.7) |
6/42 (14.3) |
0.7 |
Rheumatic disease |
2 (13.3) |
3/40 (7.5) |
0.6 |
Immunosuppressive drug usage |
3 (20) |
6 (14) |
0.7 |
cHIS Score, mean±SD |
4±1 |
4±0.9 |
0.9 |
Laboratory results, median (IQR) |
|
|
|
NLR |
6.7 (9.2) |
9 (10) |
0.5 |
CRP (mg/L) |
|
|
|
Admission |
161 (153) |
146 (141) |
0.6 |
Max |
163 (173) |
173 (138) |
0.8 |
Last |
30 (218) |
67 (153) |
0.7 |
Ferritin (pg/mL) |
|
|
|
Admission |
334 (588) |
492 (575) |
0.4 |
Max |
727 (1410) |
1032 (1961) |
0.3 |
Last |
554 (1528) |
531 (1449) |
0.7 |
D-dimer (pg/mL) |
|
|
|
Admission |
0.89 (0.65) |
1.4 (1.1) |
0.006 |
Max |
23 (17) |
12.3 (20) |
0.2 |
Last |
8.4 (14) |
5 (16.7) |
0.9 |
LDH (U/L) |
|
|
|
Admission |
348 (328) |
447 (274) |
0.5 |
Max |
676 (376) |
728 (466) |
0.6 |
Last |
486 (396) |
548 (507) |
0.5 |
Outcomes, n (%) |
|
|
|
Severe infection |
3 (20) |
9/36 (25) |
0.7 |
Pneumothorax |
2 (13.3) |
1/38 (2.6) |
0.2 |
Pulmonary thromboembolism |
1 (6.7) |
0 |
0.3 |
Myocardial infarction |
1 (6.7) |
1/38 (2.6) |
0.5 |
ICU admission |
7 (46.7) |
33 (76.7) |
0.03
(4.7) |
Intubation |
7 (46.7) |
30 (69.8) |
0.1 |
Mortality |
7 (46.7) |
30 (69.8) |
0.1 |